Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Illinois for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Illinois only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Illinois (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Safeena Enterprises Inc (NPI 1427729961)

Field	Value
Entity Type	Organization
Organization	Safeena Enterprises Inc
Address	6224 N Pulaski Rd
City	Chicago
State	IL
ZIP	60646
Taxonomy	Clinical Medical Laboratory
NPI Enumerated	September 23, 2021

Payer Source	Total Paid
Medicare	$8.6M
Medicaid	$0

Key Findings

SAFEENA ENTERPRISES INC’s Medicare billing is almost entirely concentrated in SARS–CoV–2 and related respiratory testing: the three top codes are 87637, 86328, and G2023, with 87637 reporting 45.2K claims at $140 avg paid/claim for $6.3M revenue (73.7% of this provider's total Medicare revenue), 86328 reporting 45.2K claims at $44 avg paid/claim for $2M revenue (23.2%), and G2023 reporting 11.5K claims at $23 avg paid/claim for $263.6K revenue (3.1%). The code descriptions indicate a clinical laboratory operation focused on high-volume multiplex molecular detection of respiratory pathogens and antibody immunoassay testing plus specimen collection.

Revenue concentration is extreme: the platform’s precomputed top-3 codes account for 100.0% of SAFEENA ENTERPRISES INC’s Medicare revenue, with a single code, 87637, representing 73.7% of Medicare receipts and 86328 representing another 23.2%. That concentration implies the provider’s Medicare financial performance is heavily dependent on a narrow set of respiratory/COVID-related services.

Payer mix is effectively single-payer from publicly filed data: lifetime Medicare revenue is $8.6M while there is no Medicaid billing on file. This absence of Medicaid activity means analysts should treat the entity as materially exposed to Medicare reimbursement and any commercial or private-pay contracts that are not visible in these public payer datasets.

Competitive standing on key tests is nationally prominent: SAFEENA ENTERPRISES INC ranks #5 of 1141 providers for 87637 at the 100th percentile and #3 of 119 providers for 86328 at the 98th percentile, labels the dataset calls “extreme outlier” for both codes. Those ranks indicate the provider is a major national volume player for those specific lab tests relative to peers.

By contrast, specimen collection code G2023 shows 11.5K claims and is ranked #13 of 465 providers at the 97th percentile but is described in the source data as a “typical, unremarkable volume for this code.” This suggests specimen-collection activity is present but not the primary differentiator of the business compared with its dominant testing throughput.

The provider’s NPI was enumerated on 2021-09-23 (~5 years ago), so this high-volume testing footprint was established relatively recently. Rapid build to the current volumes after enumeration is notable and may reflect targeted scaling of lab capacity or service partnerships to support large claim volumes.

Operational signals from claim and payment patterns reinforce a high-throughput laboratory model: identical claim counts (45.2K) for both 87637 and 86328 combined with differing avg paid/claim ($140 vs $44) point to a mix of higher-paid multiplex molecular assays and lower-paid immunoassays being run at scale. Analysts should interpret the payment differentials as consistent with test complexity and reimbursement policy rather than indicating additional service lines.

Financial and operational risk considerations follow directly from the data: with $8.6M in Medicare revenue and no Medicaid activity, and with 100.0% of Medicare revenue coming from three COVID/respiratory-related codes, the provider’s topline is sensitive to changes in testing demand and reimbursement for these specific codes. Any policy or market shifts that reduce demand for 87637 or 86328 would disproportionately affect this provider given the current concentration.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

3 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
87637	The lab analyst performs the technical steps to detect and differentiate severe acute respiratory syndrome coronavirus 2 (SARS–CoV–2), influenza A, influenza B, and respiratory syncytial virus (RSV)…	45,200	$140	$6.3M
86328	The lab analyst performs a single–step immunoassay to qualitatively or semiquantitatively evaluate the patient’s specimen for antibodies to the severe acute respiratory syndrome coronavirus 2…	45,220	$40	$2M
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	11,460	$20	$263.6K

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 3 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Illinois Distribution

Safeena Enterprises Inc — 1 of 3 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Illinois

Full comparison — all codes billed, vs. state median

3 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
86328	2	10	60	$40	$909K
87637	3	50	50	$140	$557.3K
G2023	7	90	400	$20	$96.5K

Nearby Providers

Other providers in the same ZIP code as Safeena Enterprises Inc, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Rainbow Lab Inc	IL	Clinical Medical Laboratory	$15.1M	$9.7M
S K Diagnostics Inc	IL	Clinical Medical Laboratory	$21.4M	$20.3K
Az Labs Limited	IL	Clinical Medical Laboratory	$12.8M	$255.6K
Cl Labs Inc.	IL	Clinical Medical Laboratory	$166.5K	$11M
Chicago Department Of Public Health	IL	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$6.2M
Aza Labs Inc	IL	Clinical Medical Laboratory	$1M	$5M
County Diagnostic Incorporation	IL	Clinical Medical Laboratory	$5.3M	$92.8K
Abdulmassih Abdulmassih	IL	Family Medicine Physician	$374.7K	$3.3M
Kyriaki Ades	IL	Dentist	$0	$3.6M
Aim One Incorporated	IL	Durable Medical Equipment & Medical Supplies	$0	$3.4M

Safeena Enterprises Inc — Billing Profile & Reimbursement Data

Sign up for Safeena Enterprises Inc — Billing Profile & Reimbursement Data policy alerts

Safeena Enterprises Inc — Billing Profile & Reimbursement Data

Sign up for Safeena Enterprises Inc — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Nearby Providers

Frequently Asked Questions

References